Eric Ammann is an accomplished professional in the field of epidemiology and market access, currently serving as the Compound Market Access Leader for Multiple Myeloma at Johnson & Johnson's Janssen Pharmaceuticals since March 2017. With a strong background in health technology assessment and real-world research, Eric has effectively managed a $1 million annual budget and led critical submissions for registrational trials. Prior roles include Associate Director positions in both Global Market Access and Epidemiology at Janssen Pharmaceuticals, where Eric developed innovative algorithms and conducted extensive studies on oncology data. Additionally, Eric contributes to academia as an Adjunct Assistant Professor at the University of Iowa, mentoring PhD students and delivering lectures on advanced epidemiological methods. Eric holds a PhD in Epidemiology, along with multiple degrees from the University of Iowa, including a Master of Science and a Master of Arts in related fields.
This person is not in any teams
This person is not in any offices